Rebamipide
Synonym(s):α-[(4-Chlorobenzoyl)amino]-1,2-dihydro-2-oxo-4-quinolinepropanoic acid hydrate;Mucosta hydrate;OPC 12759 hydrate;Proamipide hydrate
- CAS NO.：90098-04-7
- Empirical Formula: C19H15ClN2O4
- Molecular Weight: 370.79
- MDL number: MFCD00866895
- EINECS: 1308068-626-2
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-04-16 14:59:45
What is Rebamipide?
Chemical properties
White Powder
The Uses of Rebamipide
Shows antiulcer activity in rats
The Uses of Rebamipide
antiulcer, antioxidant
The Uses of Rebamipide
An inducer of endogenous prostaglandin and a oxygen-derived free radical scavenger.
Background
Rebamipide has been investigated for the treatment of Stomach Ulcer, Keratoconjunctivitis Sicca, and Gastric Adenoma and Early Gastric Cancer.
What are the applications of Application
Rebamipide is an inducer of endogenous prostaglandin and a oxygen-derived free radical scavenger
definition
ChEBI: 2-[[(4-chlorophenyl)-oxomethyl]amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid is a secondary carboxamide.
Biochem/physiol Actions
Rebamipide is an anti-ulcer agent with free-radical scavenging and anti-inflammatory effects. It has been used for mucosal protection, healing of gastroduodenal ulcers, and treatment of gastritis. It works by enhancing mucosal defense, scavenging free radicals, and temporarily activating COX-2 genes. Rebamipide significantly reduced ulcerogenesis and maintained mucosal superoxide dismutase (SOD) activity. It has also been used for the treatment of Beh?et′s disease. Rebamipide may be involved in a noval mechanism to enhance tear secretion and increase mucin levels covering conjunctiva and cornea.
Metabolism
Not Available
Properties of Rebamipide
| Melting point: | 288-290°C dec. |
| Boiling point: | 695.0±55.0 °C(Predicted) |
| Density | 1.394±0.06 g/cm3(Predicted) |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | DMSO: >5mg/mL |
| form | powder |
| pka | 3.38±0.10(Predicted) |
| color | white |
| Merck | 14,8124 |
| CAS DataBase Reference | 90098-04-7(CAS DataBase Reference) |
Safety information for Rebamipide
| Signal word | Danger |
| Pictogram(s) |
 Skull and Crossbones Acute Toxicity GHS06 |
| GHS Hazard Statements |
H301:Acute toxicity,oral |
| Precautionary Statement Codes |
P301+P310:IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
Computed Descriptors for Rebamipide
| InChIKey | ALLWOAVDORUJLA-UHFFFAOYSA-N |
Abamectin manufacturer
Synaptics Labs Private Limited
Solara Active Pharma Sciences Ltd
BDR Pharmaceuticals International Pvt Ltd
New Products
3-Pyridineacrylic acid 3-Bromo-4-fluorophenol N-Boc-Ethylenediamine cis-[2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl-4-methylbenzenesulphonate 4-Aminotetrahydropyran hydrochloride 4,5-Dibromopyridazin-3-one N-Benzyl-3-hydroxypiperidine 2-Methyl-4-nitrobenzoic acid 2-(4-bromophenyl)-2-methylpropanoic acid 4-Acetyl-2-methylbenzoicacid Acetyl-meldrum's acid Ethyl-4-Pyrazole carboxylate 2,6-Pyridinedimethanol 5,7-Dichloro-3H-Imidazo[4,5-B]Pyridine 5-Bromo-2-Methoxy-4-Methyl-3-Nitropyridine 2-Fluoro-5-Iodopyridine 2-Fluoro-5-Methylpyridine 2-Chloro-3-Bromo-5-Amiopyridine METHYL-4-(BUTYRYLAMINO)3-METHYL-5-NITROBENZOATE TRANS-CYCLOBUTANE-1,2- DICARBOXYLIC ACID 5-Nitro indazole R-(-)-5-(2-AMINO-PROPYL)-2-METHOXY-BENZENESULFONAMIDE 1,3-cyclohexanedione 4-AminophenaethylalcholRelated products of tetrahydrofuran
You may like
-
REBAMIPIDE 98%View Details -
90098-04-7 98%View Details
90098-04-7 -
Rebamipide 98%View Details
90098-04-7 -
Rebamipide 90098-04-7 98%View Details
90098-04-7 -
Rebamipide 99%View Details
90098-04-7 -
1077-28-7 >98%View Details
1077-28-7 -
(S)-methyl-2-(2-chlorophenyl)2-(2thiophen-2-yl) ethyl amino) acetate HCI >98%View Details
141109-19-5 -
TosMIC 36635-61-7 >98%View Details
36635-61-7